CLEARPOINT NEURO INC (CLPT)
US18507C1036 - Common Stock
7 Penny Stocks That Could Make You a Fortune (If You Dare)
These penny stocks offer robust operational opportunities amid wider economic and market concerns pushing weaker companies downward.
ClearPoint Neuro félicite son partenaire AviadoBio pour son premier patient traité dans le cadre de son essai clinique ASPIRE-FTD évaluant l’AVB-101 dans la démence fronto-temporale avec mutations du gène GRN
Les centres ASPIRE-FTD dans l’UE et aux États-Unis utiliseront la navigation ClearPoint® avec la canule SmartFlow® pour l’administration de thérapie...
ClearPoint Neuro beglückwünscht seinem Partner AviadoBio zur Behandlung des ersten Patienten in der klinischen Studie ASPIRE-FTD, in der AVB-101 für frontotemporale Demenz mit GRN-Mutationen evaluiert wird
Prüfzentren für ASPIRE-FTD in der EU und den USA verwenden ClearPoint® Navigation zusammen mit der SmartFlow®-Kanüle für die intrathalamische Gentherapie...
ClearPoint Neuro si congratula con il proprio partner AviadoBio per il primo paziente trattato nello studio clinico ASPIRE-FTD, che valuta la terapia genica sperimentale AVB-101 per la demenza frontotemporale con mutazioni GRN
I siti ASPIRE-FTD nell’UE e negli Stati Uniti utilizzeranno la navigazione ClearPoint® insieme alla cannula SmartFlow® per la somministrazione della...
ClearPoint Neuro felicita a su socio AviadoBio por el primer paciente tratado en su ensayo clínico ASPIRE-FTD que evalúa AVB-101 en personas con demencia frontotemporal con mutaciones en el gen GRN
Los centros ASPIRE-FTD de la UE y EE. UU. ...
ClearPoint Neuro feliciteert partner AviadoBio met de behandeling van de eerste patiënt in klinisch onderzoek ASPIRE-FTD, waarin AVB-101 wordt geëvalueerd voor frontotemporale dementie met GRN-mutaties
De onderzoekscentra van ASPIRE-FTD in de EU en de VS zullen gebruikmaken van ClearPoint® Navigation in combinatie met de SmartFlow® Cannula voor de...
ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
ClearPoint Neuro platform and SmartFlow Cannula to be used by all centers in AviadoBio's ASPIRE-FTD gene therapy trial treating frontotemporal dementia...
ClearPoint Neuro Becomes Oversold (CLPT)
The 3 Most Promising MedTech Stocks to Invest In Now
MedTech stocks are often overlooked despite the inherent healthcare growth trajectory and industry-wide innovative spirit.
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ClearPoint Neuro, Inc. (NASDAQ: CLPT)
/PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating ClearPoint Neuro, Inc. (NASDAQ: CLPT) on behalf of the company's shareholders. The...
ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency
ClearPoint Neuro's partner's completed BLA Submission for Upstaza™ would be first disease-modifying treatment for AADC Deficiency in the US....
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results
ClearPoint Neuro reports 32% growth in fourth quarter as compared to fourth quarter of 2022. Biologics revenue increased 49% YOY. ...
The Top 7 Under-$15 Stocks to Buy in March 2024
These under-$15 stocks to buy are one of the few deals remaining in today's economic environment. Don't miss out.
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024
SOLANA BEACH, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global device, cell, and gene...
ClearPoint Neuro prices offering of about 2.3M shares (NASDAQ:CLPT)
ClearPoint Neuro announces pricing of its underwritten public offering of 2,307,694 shares of common stock at $6.50 per share, with an option for additional...
ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock
SOLANA BEACH, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene...
ClearPoint Neuro stock falls 10% after it announces an equity raise (NASDAQ:CLPT)
ClearPoint Neuro (CLPT) announces a public offering of common stock and grants underwriters an option to purchase additional shares.
ClearPoint Neuro Launches Proposed Public Offering of Common Stock
SOLANA BEACH, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene...
Tech Trailblazers: 7 Small-Cap Stocks on the Verge of a Breakthrough
These small-cap tech stocks are well on their way to a meteoric and historic rise, but it isn't too late to jump on the bandwagon.
The 3 Up-and-Coming Stocks That Could Make Your February Unforgettable
Finding an up-and-coming stock worth investing in is harder than it used to be, but you don't have to look far if you check out this list.
The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.
Looking for the next generational winner in healthcare stocks? These are three of the top prospects today.
3 Strong Buy Healthcare Stocks to Add to Your February Must-Watch List
These strong buy healthcare stocks are among analysts' favorite picks, and their strong market position tells us why.
3 Small-Cap Healthcare Stocks to Buy and Hold Forever: January 2024
Small-cap healthcare stocks combine relative cheapness with advanced innovations including AI, automation, and more.
3 Small-Cap Healthcare Stocks to Buy and Hold Forever: January 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Small-cap healthcare stocks might be the next stock market goldmine, but many i...
ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo
First successful procedure with ClearPoint Prism Neuro Laser Therapy System and Neuro Navigation System by Kaleida Health in Buffalo....
ClearPoint Neuro receives EU okay for devices, Calif. plant (NASDAQ:CLPT)
ClearPoint Neuro (CLPT) has received EU clearance for its SmartTwist MR Hand Drill and SmartTip MR Drill Kit along with an updated certification for its new California plant.
ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe
ClearPoint Neuro announces first EU MDR certification success and approval to ship product to Europe from its Carlsbad, California manufacturing facility....
ClearPoint Neuro annoncerer første EU MDR certificeringssucces og godkendelse til at sende produkt til Europa
SOLANA BEACH, Californien, Jan. 22, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (
ClearPoint Neuro annonce être arrivé pour la première fois au terme du processus de certification de conformité au Règlement européen MDR et obtenu l’autorisation d’expédier son produit en Europe
SOLANA BEACH, Californie, 22 janv. 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq : CLPT (la « Société »), une entreprise internationale...
ClearPoint Neuro gibt erste erfolgreiche EU-MDR-Zertifizierung und Genehmigung zur Lieferung von Produkten nach Europa bekannt
SOLANA BEACH, Kalifornien, Jan. 22, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (das „Unternehmen“), ein weltweit tätiges Unternehmen...
ClearPoint Neuro tillkännager sin första EU MDR-certifiering och godkännande att skicka produkter till Europa
SOLANA BEACH, Kalif., Jan. 22, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (”Företaget”), ett globalt företag inom medicinteknik och...
ClearPoint Neuro gets FDA clearance for SmartFrame OR (NASDAQ:CLPT)
ClearPoint Neuro(CLPT) has received FDA clearance for its SmartFrame OR Stereotactic System for neurological procedures. Read more here.
7 Small-Cap Stocks With Huge Potential Flying Under the Radar
Small-cap stocks are massively undervalued and represent a unique investment opportunity for traders in 2024.
Tuesday Sector Leaders: Manufacturing, Medical Instruments & Supplies
ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue
SOLANA BEACH, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company...